|
37 Companies |
|
62 Products |
|
62 Products |
|
62 Mechanisms of Action |
|
5 Trials |
|
685 News |
|
| «12...234567891011121314 |
- |||||||||| New P3 trial: Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity (clinicaltrials.gov) - Feb 1, 2012
P3, N=66, Completed, Sponsor: APOGEPHA Arzneimittel GmbH
- tolterodine / Generic mfg.
Trial termination: A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. (clinicaltrials.gov) - Jan 31, 2012
P4, N=19, Terminated, Sponsor: Brigham and Women's Hospital
Recruiting --> Terminated; New department chairman instructed PI to discontinue study.
- tolterodine / Generic mfg.
Enrollment change: A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. (clinicaltrials.gov) - Jan 31, 2012
P4, N=19, Terminated, Sponsor: Brigham and Women's Hospital
Recruiting --> Terminated; New department chairman instructed PI to discontinue study. N=49 --> 19
- ||| tolterodine / Generic mfg.
Enrollment change: MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. (clinicaltrials.gov) - Jan 31, 2012
P2, N=118, Completed, Sponsor: Sanofi
N=49 --> 19 N=81 --> 118
- losartan / Generic mfg.
Trial completion: Angiotensin II Blockade for Chronic Allograft Nephropathy (clinicaltrials.gov) - Jan 29, 2012
P4, N=153, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
N=81 --> 118 Active, not recruiting --> Completed
- || New P3 trial: BETTUR PD: Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease (clinicaltrials.gov) - Jan 26, 2012
P3, N=60, Recruiting, Sponsor: Atlanta VA Medical Center
- ||| Trial completion: Effectiveness and Safety of Bulkamid (clinicaltrials.gov) - Jan 18, 2012
P=N/A, N=125, Completed, Sponsor: Contura
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial termination: ACCEPTANCE: Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (clinicaltrials.gov) - Jan 12, 2012
P4, N=17, Terminated, Sponsor: Medtronic International Trading Sarl
Active, not recruiting --> Completed Recruiting --> Terminated; difficulty in the enrolment
- Enrollment change: ACCEPTANCE: Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (clinicaltrials.gov) - Jan 12, 2012
P4, N=17, Terminated, Sponsor: Medtronic International Trading Sarl
Recruiting --> Terminated; difficulty in the enrolment N=72 --> 17
- Trial termination: Injectable Bulking Agent Needle Guide (clinicaltrials.gov) - Jan 8, 2012
P1, N=17, Terminated, Sponsor: Carbon Medical Technologies
N=72 --> 17 Recruiting --> Terminated
- ||||| Vesicare (solifenacin) / Astellas
New P4 trial: A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence (clinicaltrials.gov) - Jan 3, 2012
P4, N=300, Recruiting, Sponsor: Astellas Pharma Inc
- || Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
New P3 trial: Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) (clinicaltrials.gov) - Dec 29, 2011
P3, N=380, Recruiting, Sponsor: NICHD Pelvic Floor Disorders Network
- New P1 trial: Urinary Incontinence in an Inpatient Rehab Unit (clinicaltrials.gov) - Dec 22, 2011
P1, N=15, Active, not recruiting, Sponsor: Anne Deutsch
- |||||| iltamiocel (AMDC-USR) / Cook MyoSite
Enrollment open: Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study (clinicaltrials.gov) - Dec 13, 2011
P3, N=246, Recruiting, Sponsor: Cook MyoSite
Recruiting --> Terminated Not yet recruiting --> Recruiting
- Trial completion, Surgery: Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled Study (clinicaltrials.gov) - Dec 13, 2011
P=N/A, N=40, Completed, Sponsor: University Hospital Inselspital, Berne
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial completion: Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence (clinicaltrials.gov) - Nov 24, 2011
P=N/A, N=150, Completed, Sponsor: University of Zurich
Recruiting --> Completed Not yet recruiting --> Completed
- Clinical: Urinary Continence Index for Prediction of Urinary Incontinence in Older Women (clinicaltrials.gov) - Nov 22, 2011
P=N/A, N=1, Active, not recruiting, Sponsor: Ananias Diokno
- Soliris (eculizumab) / AstraZeneca
Trial completion: Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH) (clinicaltrials.gov) - Nov 17, 2011
P1/2, N=7, Completed, Sponsor: Alexion Pharmaceuticals
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | New P1 trial: A Pilot Study to Evaluate Safety and Performance of Neuromuscular Electrical Stimulation With the Inko RS Device for the Treatment of Stress Urinary Incontinence (clinicaltrials.gov) - Nov 14, 2011
P1, N=20, Completed, Sponsor: Bio-Medical Research, Ltd.
- |||| Trial completion: Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency (clinicaltrials.gov) - Nov 14, 2011
P2, N=66, Completed, Sponsor: American Oriental Bioengineering, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial termination: Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy (clinicaltrials.gov) - Nov 13, 2011
P=N/A, N=25, Terminated, Sponsor: Central Carolina Surgery, PA
Active, not recruiting --> Completed Recruiting --> Terminated; study size reached
- || New P3 trial: Electromagnetic Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder (clinicaltrials.gov) - Nov 1, 2011
P3, N=130, Terminated, Sponsor: EMKinetics, Inc
- pioglitazone / Generic mfg.
Trial completion: Influence of Pioglitazone for Renal Transplant Function in Diabetics (clinicaltrials.gov) - Oct 26, 2011
P3, N=0, Completed, Sponsor: Technische Universit
Recruiting --> Terminated; study size reached Active, not recruiting --> Completed
- Clinical: Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter (clinicaltrials.gov) - Oct 24, 2011
P=N/A, N=160, Enrolling by invitation, Sponsor: University of Massachusetts, Worcester
- rosiglitazone / Generic mfg.
Trial completion: Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy (clinicaltrials.gov) - Oct 19, 2011
P=N/A, N=28, Completed, Sponsor: Technische Universit
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment change: The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease (clinicaltrials.gov) - Oct 11, 2011
P3, N=85, Recruiting, Sponsor: Albert Einstein College of Medicine of Yeshiva University
Active, not recruiting --> Completed N=128 --> 85
- | Trial completion: SECURiTy: Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence (clinicaltrials.gov) - Oct 4, 2011
P3, N=281, Completed, Sponsor: The Cleveland Clinic
N=128 --> 85 Active, not recruiting --> Completed
- | CCX140 / Amgen, CSL Behring
New P2 trial: A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria (clinicaltrials.gov) - Sep 22, 2011
P2, N=20, Active, not recruiting, Sponsor: ChemoCentryx
- |||||||||| paricalcitol / Generic mfg.
New P3 trial: Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients (clinicaltrials.gov) - Sep 18, 2011
P3, N=166, Recruiting, Sponsor: University Medical Centre Ljubljana
- || Enrollment change: TVT Worldwide Registry (clinicaltrials.gov) - Sep 14, 2011
P=N/A, N=1407, Completed, Sponsor: Ethicon, Inc.
Active, not recruiting --> Completed N=5000 --> 1407
- ||| Trial completion: TVT Worldwide Registry (clinicaltrials.gov) - Sep 14, 2011
P=N/A, N=1407, Completed, Sponsor: Ethicon, Inc.
N=5000 --> 1407 Active, not recruiting --> Completed
- desmopressin / Generic mfg.
New P4 trial: Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study (clinicaltrials.gov) - Sep 13, 2011
P4, N=50, Recruiting, Sponsor: University Hospital, Ghent
- ||| Enrollment change: InSite - OAB: InSite for Over Active Bladder (clinicaltrials.gov) - Sep 6, 2011
P4, N=571, Active, not recruiting, Sponsor: MedtronicNeuro
Active, not recruiting --> Completed N=297 --> 571
- ||||| Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Enrollment closed: Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence (clinicaltrials.gov) - Aug 30, 2011
P3, N=839, Active, not recruiting, Sponsor: Allergan
N=297 --> 571 Recruiting --> Active, not recruiting
- ||||| Vanrafia (atrasentan) / Novartis
New P2 trial: Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan (clinicaltrials.gov) - Aug 25, 2011
P2, N=58, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
- Enrollment change, Surgery: Evaluate Women After Vaginal Surgery for Urinary Symptoms and Sexual Function (clinicaltrials.gov) - Aug 21, 2011
P=N/A, N=41, Completed, Sponsor: William Beaumont Hospitals
Recruiting --> Active, not recruiting N=120 --> 41
- Trial completion, Surgery: Evaluate Women After Vaginal Surgery for Urinary Symptoms and Sexual Function (clinicaltrials.gov) - Aug 21, 2011
P=N/A, N=41, Completed, Sponsor: William Beaumont Hospitals
N=120 --> 41 Active, not recruiting --> Completed
- | Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
New P4 trial: Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease (clinicaltrials.gov) - Aug 18, 2011
P4, N=20, Completed, Sponsor: Stanford University
- ||| Trial completion: Comparison of Two Intermittent Urinary Catheters (clinicaltrials.gov) - Aug 9, 2011
P=N/A, N=91, Completed, Sponsor: Hollister Incorporated
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=10, Completed, Sponsor: University of Utah
Recruiting --> Completed N=20 --> 10
- Trial completion: The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=10, Completed, Sponsor: University of Utah
N=20 --> 10 Recruiting --> Completed